注射用哌拉西林钠舒巴坦钠在小儿肺炎临床疗效及不良反应的影响  

Effect of piperacillin sodium and Sulbactam Sodium for injection on clinical efficacy and adverse reactions of children with pneumonia

作　　者：陈玲[1] 陈嵘峰 CHEN Ling;CHEN Rong-feng(Department of Pediatrics,BOLUO branch,Huizhou Central People’s Hospital,Huizhou Guangdong 516100,China)

机构地区：[1]惠州市中心人民医院博罗分院普儿科,广东惠州516100

出　　处：《医学食疗与健康》2021年第5期47-48,共2页Medical Diet and Health

摘　　要：目的:探讨注射用哌拉西林钠舒巴坦钠在小儿肺炎临床治疗中的效果与安全性分析。方法:选取我院2018年3月至2020年3月在我院治疗的54例肺炎患儿,根据住院先后顺序随机分为30例对照组和24例观察组。对照组用头孢替安治疗,观察组进行注射用哌拉西林钠舒巴坦钠治疗,对比分析两组患儿疗效及不良反应率德国情况。结果:治疗后观察组有效率(83.33%)高于对照组(56.67%),差异用统计学意义(P<0.05);观察组患儿不良反应率(20.83%)低于对照组(46.67%),有统计学意义(P<0.05)。结论:注射用哌拉西林钠舒巴坦钠能提高小儿肺炎的治疗效果,不良反应少,药物更安全,适合推广。Objective:To investigate the effect and safety of piperacillin sodium and Sulbactam Sodium for injection in the clinical treatment of children with pneumonia.Methods:54 cases of pneumonia children in our hospital from March 2018 to March 2020 were selected and randomly divided into 30 cases of control group and 24 cases of observation group according to the sequence of hospitalization.The control group was treated with cefotiam,and the observation group was treated with piperacillin sodium and Sulbactam Sodium for injection.The efficacy and adverse reaction rate of the two groups were compared and analyzed.Results:after treatment,the effective rate of observation group(83.33%)was higher than that of control group(56.67%),the difference was statistically significant(P<0.05);the adverse reaction rate of observation group(20.83%)was lower than that of control group(46.67%),with statistical significance(P<0.05).Conclusion:piperacillin sodium and Sulbactam Sodium for injection can improve the treatment effect of pneumonia in children,with less adverse reactions and safer drug,which is suitable for promotion.

关 键 词：肺炎 哌拉西林舒巴坦钠 腹泻 皮疹 水肿 

分 类 号：R725.6[医药卫生—儿科]